Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic modification in Parkinson’s disease
Hao Song, Juanli Chen, Jin Huang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 23

Showing 23 citing articles:

Current Advances in the Therapeutic Potential of Scutellarin: Novel Applications, Mechanisms, and Future Challenges.
Great Iruoghene Edo, Alice Njolke Mafe, Patrick Othuke Akpoghelie, et al.
Phytomedicine Plus (2025), pp. 100754-100754
Open Access | Times Cited: 2
Role of histone modifications in neurogenesis and neurodegenerative disease development
Anqi Zhao, Wenhong Xu, Rui Han, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102324-102324
Closed Access | Times Cited: 13
Melatonin-Loaded Nanoparticles Augment Mitophagy to Retard Parkinson’s Disease
Liku Biswal, Mohammed Nadim Sardoiwala, Avinash Chandra Kushwaha, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 7, pp. 8417-8429
Closed Access | Times Cited: 5
Exposure to Metals, Pesticides, and Air Pollutants: Focus on Resulting DNA Methylation Changes in Neurodegenerative Diseases
Andrea Stoccoro, Fabio Coppedè
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1366-1366
Open Access | Times Cited: 5
Interplay of human gastrointestinal microbiota metabolites: Short-chain fatty acids and their correlation with Parkinson’s disease
Jiaji Liu, Qi Chen, SU Rui-jun
Medicine (2024) Vol. 103, Iss. 17, pp. e37960-e37960
Open Access | Times Cited: 4
G9a an Epigenetic Therapeutic Strategy for Neurodegenerative Conditions: From Target Discovery to Clinical Trials
Aina Bellver‐Sanchís, Marta Ribalta‐Vilella, Alba Irisarri, et al.
Medicinal Research Reviews (2025)
Open Access
Values of epigenetic markers in Parkinson's disease as biomarkers and therapeutic targets: A narrative review
Dhruv Parikh, Manan Shah
NeuroMarkers. (2025), pp. 100037-100037
Open Access
IDENTIFICATION OF EPIGENETIC CHANGE PATTERNS IN NEURODEGENERATIVE DISEASES (literature review)
I. M. Trofimova, V. V. Mikhajlovska, С. В. Зябліцев
Medical Science of Ukraine (MSU) (2025) Vol. 21, Iss. 1, pp. 140-148
Open Access
Exploration of the Therapeutic Potential of the Epigenetic Modulator Decitabine on 6-OHDA-Induced Experimental Models of Parkinson’s Disease
Shobha Kumari, Rajesh Pradhan, Sunil Kumar Dubey, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Editorial: Methylation in the human brain
Sheila T. Nagamatsu, Francisco Navarrete, María S. García‐Gutiérrez
Frontiers in Genetics (2025) Vol. 16
Open Access
Epigenome-wide association study of peripheral immune cell populations in Parkinson’s disease
Maren Stolp Andersen, Ingvild Sørum Leikfoss, Ina Skaara Brorson, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 10
Chemical Methods to Identify Epigenetic Modifications in Cytosine Bases
N Madhumitha, P. Santhosh Kumar, Debasish Manna
Chemistry - An Asian Journal (2024) Vol. 19, Iss. 3
Closed Access | Times Cited: 2
Advancements in Neurodegenerative Diseases: Pathogenesis and Novel Neurorestorative Interventions
Wenyong Gao, Shiyuan Jing, Chao He, et al.
Journal of Neurorestoratology (2024), pp. 100176-100176
Open Access | Times Cited: 2
Epigenetic Alterations of Cognition Functions in Parkinson's Disease
Fatemeh Hasani, Payam Ahmadi, Mahdi Masrour, et al.
(2024)
Open Access | Times Cited: 1
Histone post-translational modification and heterochromatin alterations in neurodegeneration: revealing novel disease pathways and potential therapeutics
Raven M. A. Fisher, Mariana P. Torrente
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 1
Glutathione S-transferase: A keystone in Parkinson's disease pathogenesis and therapy
Pratyush Padhan, Simran Simran, Neeraj Kumar, et al.
Molecular and Cellular Neuroscience (2024), pp. 103981-103981
Closed Access | Times Cited: 1
Epigenetics: the missing link between environmental exposures and Parkinson's disease?
Efthalia Angelopoulou, Christina Piperi
Epigenomics (2024) Vol. 16, Iss. 13, pp. 921-927
Closed Access
Cardiovascular history and risk of idiopathic Parkinson’s disease: a cross-sectional observational study
Shubhra Acharya, Andrew I. Lumley, Yvan Devaux, et al.
BMC Neuroscience (2024) Vol. 25, Iss. 1
Open Access
lncRNA SOX21-AS1 promotes activation of BV2 cells via epigenetically silencing of SOCS3 and aggravates Parkinson's disease
Dan Feng, Yun Liu, Fangya Zuo, et al.
Gerontology (2024) Vol. 70, Iss. 10, pp. 1063-1073
Closed Access
Glutathione S-Transferases: Potential Implications in Parkinson's Disease.
Sonia Verma, Pratyush Padhan, Simran Simran, et al.
(2024)
Open Access
The Multifaceted Impact of Environmental Pollutants on Health and Ecosystems
Marina Piscopo, Carmela Marinaro, Gennaro Lettieri
Biomolecules (2024) Vol. 14, Iss. 8, pp. 1021-1021
Open Access
The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies
Muhammad Abu Talha Safdar Hashmi, Hooriya Fatima, Sadia Ahmad, et al.
Ibrain (2024) Vol. 10, Iss. 4, pp. 395-426
Open Access
Epigenetic modulation in medicine: Regulation of gene expression in the context of pathogenesis and therapy
M. A. Omarov, A. R. Mulyukov, R. V. Khalitov, et al.
Acta Biomedica Scientifica (East Siberian Biomedical Journal) (2024) Vol. 9, Iss. 6, pp. 22-33
Open Access
Page 1

Scroll to top